Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphangioleiomyomatosis”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Early research (Phase 1)UnknownNCT04273334
What this trial is testing

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Who this might be right for
Lymphatic Disorders
Peking Union Medical College Hospital 90
Not applicableUnknownNCT05617105
What this trial is testing

Molecular Characterization of Perivascular Epithelioid Cell Tumors

Who this might be right for
Perivascular Epithelioid Cell Tumor, Malignant
University Hospital, Strasbourg, France 100
Testing effectiveness (Phase 2)Study completedNCT03131999
What this trial is testing

LAM Pilot Study With Imatinib Mesylate

Who this might be right for
Lymphangioleiomyomatosis
Medical University of South Carolina 18
Not applicableStudy completedNCT02009241
What this trial is testing

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
University of Sao Paulo General Hospital 40
Not applicableStudy completedNCT00960895
What this trial is testing

Pulmonary Hypertension in Lymphangioleiomyomatosis

Who this might be right for
LymphangioleiomyomatosisPulmonary Hypertension
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 20
Testing effectiveness (Phase 2)Study completedNCT00005906
What this trial is testing

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Who this might be right for
LymphangioleiomyomatosisLymphangiomyomasPleural Effusions+1 more
National Heart, Lung, and Blood Institute (NHLBI) 4
Not applicableEnded earlyNCT02654340
What this trial is testing

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Who this might be right for
Hypomelanotic MaculesFacial AngiofibromaShagreen Patches+6 more
CENTOGENE GmbH Rostock 20
Very early researchUnknownNCT05087134
What this trial is testing

Characterizing LAM With 11C-Choline PET/CT

Who this might be right for
Lymphangioleiomyomatosis
Peking Union Medical College Hospital 50
Not applicableLooking for participantsNCT00001465
What this trial is testing

Study of the Disease Process of Lymphangioleiomyomatosis

Who this might be right for
Lung DiseasePneumothoraxTuberous Sclerosis+1 more
National Heart, Lung, and Blood Institute (NHLBI) 2,000
Testing effectiveness (Phase 2)Study completedNCT03304678
What this trial is testing

Discovery of Sirolimus Sensitive Biomarkers in Blood

Who this might be right for
Lymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 33
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Not applicableLooking for participantsNCT07304856
What this trial is testing

Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex

Who this might be right for
Lymphangioleiomyomatosis (LAM)Extracellular Vesicles; Generation and Function
University of Milan 80
Not applicableStudy completedNCT00001869
What this trial is testing

Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)

Who this might be right for
Leiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 400
Large-scale testing (Phase 3)Study completedNCT00414648
What this trial is testing

Efficacy and Safety of Sirolimus in LAM

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 89
Not applicableLooking for participantsNCT01484236
What this trial is testing

National Lymphangioleiomyomatosis Registry, France

Who this might be right for
Lymphangioleiomyomatosis
Vincent COTTIN 200
Not applicableStudy completedNCT00552955
What this trial is testing

Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women

Who this might be right for
LymphangioleiomyomasTuberous SclerosisLymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 35
Not applicableLooking for participantsNCT06405997
What this trial is testing

The Genotype and Phenotype of Lymphangioleiomyomatosis

Who this might be right for
Sporadic LymphangioleiomyomatosisTSC-associated Lymphangioleiomyomatosis
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT03253913
What this trial is testing

Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 25
Testing effectiveness (Phase 2)Study completedNCT01059318
What this trial is testing

Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
Novartis Pharmaceuticals 24
Not applicableLooking for participantsNCT05676099
What this trial is testing

TSC Biosample Repository and Natural History Database

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
National Tuberous Sclerosis Association 5,000
Next Page